THNR Price Forecast & ETF Analysis. Dividend · Expense Ratio · Holdings · NAV · RSI · MACD | US Stocks Today
Oct 23 at 3:55 PM ET (Korea 10/24 04:55)
Full metrics table
| Category | Global or ExUS Equities - Industry Sector | Expense | 0.59% | Return% 1Y | 7.92% | Total Holdings | 22 | Perf Week | 0.8% | Volume | 385 |
| Asset Type | Equities (Stocks) | AUM | $6M | Return% 3Y | - | NAV | $24.95 | Perf Month | -3.82% | Avg Volume | 0.00M |
| ETF Type | Global Equities | Dividend TTM | $0.41 (1.67%) | Return% 5Y | - | 52W High | -11.6% | Perf Quarter | -4.09% | Rel Volume | 0.3 |
| Active/Passive | Passive | Div Gr. 3/5Y | - | Return% 10Y | - | 52W Low | 7.91% | Perf Half Y | 0.91% | Prev Close | $24.95 |
| IPO | 2024/5/21 | Flows% 1M | 0% | Return% SI | 0.32% | RSI (14) | 45.86 | Perf YTD | -2.06% | Price | $24.70 |
| Beta | 0.43 | Flows% 3M | 15.21% | Flows% YTD | 115.58% | Flows% 1Y | 115.58% | Perf Year | 6.65% | Volatility(W/M) | 0.27% 0.99% |
| SMA20 | 0.16% | SMA50 | -4.01% | SMA200 | -2.54% | ATR | 0.36 | ||||
Amplify Weight Loss Drug & Treatment ETF seeks investment results that generally correspond to the performance (before fees and expenses) of the VettaFi Weight Loss Drug & Treatment Index. The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists (glucagon-like peptide) seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.
The top 3 make up 100% of the fund
Concentrated in a few names. When they swing, the ETF swings with them.
Over the past 1 year, roughly in the middle
12% below its 1-year high.
Traded less than usual. That is 30% of its average volume.
Long-term returns are roughly flat
Tap to view numbers
The price swings a lot
At its worst (August 2024) it fell 33% and took 498 days to recover.
Tap to view numbers
The dividend is on the small side
Pays 1.67% annually in dividends.
Tap to view numbers
Money keeps flowing in
Over the past year, new money equal to 115.6% of assets came in.
Tap to view numbers
CURE Direxion Daily Healthcare Bull 3X ETF 191M 
RXL ProShares Ultra Health Care 2X Shares 107M 
XLVI State Street Health Care Select Sector SPDR Premium Income ETF 33M 
TBXU Direxion Daily Biotech Top 5 Bull 2X ETF 3M 
RXD-1× ProShares UltraShort Health Care -2x Shares 3M 
PPH VanEck Pharmaceutical ETF 0.36% 
TRFK Pacer Data and Digital Revolution ETF 0.49% 
NXTG First Trust Indxx NextG ETF 0.7% 
CLOU Global X Cloud Computing ETF 0.68% 
WQTM WisdomTree Quantum Computing Fund 0.45% 
HAUZ Xtrackers International Real Estate ETF 0.1% 
VNQI Vanguard Global ex-U.S. Real Estate ETF 0.12% 
PBPH Portfolio Building Block World Pharma and Biotech Index ETF 0.13% 
FAQ
How many holdings does THNR have?
THNR holds a total of 22 securities, with an AUM of approximately $6M.
Does THNR pay dividends (distributions)?
THNR's distribution yield is approximately 1.67%.
What is the 52-week high and low for THNR?
THNR has recorded a 52-week high of $27.94 and a low of $22.89.
